Pfizer BNT 162b2 COVID-19 vaccine–induced fulminant myopericarditis: A case study

IF 1.4 4区 医学 Q3 CRITICAL CARE MEDICINE
Natalie L. Montarello Cardiologist, MBBS, FRACP , Hao Zheng Wong Intensivist, MBBS, FCICM , Ashlee Jeffries Cardiology Registrar, MBBS , Griffith B. Perkins Researcher in Immunology, BSc(Adv), PhD , Pravin Hissaria Immunologist, MBBS, MD, DM, FRACP, FRCPA , Michael B. Stokes Cardiologist, MBBS, FRACP , Eamon Raith Intensivist, MBBS, MACCP, PhD , Karen Teo Cardiologist, MBBS, FRACP, PhD , Julie Bradley Cardiologist, MBBS FRACP, FCSANZ
{"title":"Pfizer BNT 162b2 COVID-19 vaccine–induced fulminant myopericarditis: A case study","authors":"Natalie L. Montarello Cardiologist, MBBS, FRACP ,&nbsp;Hao Zheng Wong Intensivist, MBBS, FCICM ,&nbsp;Ashlee Jeffries Cardiology Registrar, MBBS ,&nbsp;Griffith B. Perkins Researcher in Immunology, BSc(Adv), PhD ,&nbsp;Pravin Hissaria Immunologist, MBBS, MD, DM, FRACP, FRCPA ,&nbsp;Michael B. Stokes Cardiologist, MBBS, FRACP ,&nbsp;Eamon Raith Intensivist, MBBS, MACCP, PhD ,&nbsp;Karen Teo Cardiologist, MBBS, FRACP, PhD ,&nbsp;Julie Bradley Cardiologist, MBBS FRACP, FCSANZ","doi":"10.1016/j.ccrj.2023.06.005","DOIUrl":null,"url":null,"abstract":"<div><p>The use of mRNA COVID-19 vaccine can on rare occasions cause life-threatening, fulminant myopericarditis. This case report demonstrates previously reported benefit of early use of venoarterial extracorporeal membrane oxygenation mechanical assistance and supports the use of intravenous highly purified immunoglobulin pharmacotherapy to help achieve a good clinical outcome.</p></div>","PeriodicalId":49215,"journal":{"name":"Critical Care and Resuscitation","volume":null,"pages":null},"PeriodicalIF":1.4000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical Care and Resuscitation","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1441277223000261","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

The use of mRNA COVID-19 vaccine can on rare occasions cause life-threatening, fulminant myopericarditis. This case report demonstrates previously reported benefit of early use of venoarterial extracorporeal membrane oxygenation mechanical assistance and supports the use of intravenous highly purified immunoglobulin pharmacotherapy to help achieve a good clinical outcome.

辉瑞BNT 162b2疫苗诱导的暴发性心包炎病例研究
使用mRNA COVID-19疫苗在极少数情况下会导致危及生命的暴发性心包炎。本病例报告证实了先前报道的早期使用静脉动脉体外膜氧合机械辅助的益处,并支持使用静脉高纯度免疫球蛋白药物治疗以帮助获得良好的临床结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Critical Care and Resuscitation
Critical Care and Resuscitation CRITICAL CARE MEDICINE-
CiteScore
7.70
自引率
3.40%
发文量
44
审稿时长
>12 weeks
期刊介绍: ritical Care and Resuscitation (CC&R) is the official scientific journal of the College of Intensive Care Medicine (CICM). The Journal is a quarterly publication (ISSN 1441-2772) with original articles of scientific and clinical interest in the specialities of Critical Care, Intensive Care, Anaesthesia, Emergency Medicine and related disciplines. The Journal is received by all Fellows and trainees, along with an increasing number of subscribers from around the world. The CC&R Journal currently has an impact factor of 3.3, placing it in 8th position in world critical care journals and in first position in the world outside the USA and Europe.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信